Abbott introduces Jot Dx insertable cardiac monitor for difficult-to-detect abnormal heart rhythms
Abbott has recently launched in the US their Jot Dx, the company’s latest insertable cardiac monitor (ICM). The Jot Dx ICM gives clinicians and hospitals control of how they manage the flow of information through a unique feature to view either all abnormal heart rhythm data or to simplify which irregular heart rhythms are recorded with a ‘key episodes’ option.
This technology allows for accurate remote detection of cardiac arrythmia in patients. Jot Dx ICM is supported by SyncUP, a personalized service that delivers one-on-one training and education to help patients get connected and stay connected to their ICM.
To better help physicians diagnose their patients’ abnormal heart rhythms, Jot Dx ICM continuously monitors patient cardiac rhythms 24/7 and connects directly to myMerlin, a downloadable mobile app that transmits data in real-time to both the clinician and patient.
For the first time in an ICM, Jot provides clinicians increased control over patient monitoring, with an option to toggle between viewing only three key episodes or all episodes depending on individual patient needs to make an accurate diagnosis. This functionality reduces overall data burden. For example, for every 100 patients, it can save clinic staff up to 120 hours per month in reviewing electromyogram (EGM) transmissions, while also providing the flexibility needed to find hard-to-detect arrhythmias.
In addition to improving workflow for physicians, clinics and health systems monitoring patients with potential abnormal heart rhythms, Abbott is also improving how patients interact with their device. A key element in the setup of Jot Dx ICM and the myMerlin mobile app is the new SyncUP support service, which Abbott offers on select products as part of its connected care portfolio. With SyncUP, an Abbott support expert will enrol a patient with a newly implanted device in the system, orient them through getting to know their new heart monitoring device and confirm connection to the myMerlin app.
SyncUP is designed to educate people about the technology from the comfort of home, which has been shown to increase information retention and encourage compliance, and helps reduce in-clinic burden. Currently, the process to ensure a patient is connected is conducted in the healthcare facility directly following the device’s implant, which prolongs the stay for the patient. SyncUP also support patients with Abbott’s implantable defibrillator, Gallant ICD.
